

HY-147040 · 5 mg
MedChemExpress · Cat: HY-147040
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/abn401.html
Description
ABN401 is an orally active and selective ATP-competitive c-MET inhibitor with an IC50 of 10 nM. ABN401 is cytotoxic to MET-addicted cancer cells with the IC50 of 2-43 nM. ABN401 has bioavailability in rats and dogs of 42.1-56.2 % and 27.4-37.7 %, respectively. ABN401 has antitumor activity.







